HOLUKA EUGENE MYRON received a stock award from CITIUS ONCOLOGY, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/23/2025ACC: 0001213900-25-090610
+300K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
300K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+300K
Price / share
—
Trade value
—
% of position
New position
9/19/2025
0.00→300K
Total
Net shares
+300K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/19/2025 | A · Award | +300K | — | — | New position | 0.00 | 300K |
| Total | +300K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
125K
Shares owned
125K
Exercise price
1.07
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
150K
Shares owned
150K
Exercise price
2.15
Expiration
—
Exercise window
—
Total
Underlying
275K
Owned
275K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 1.07 | — | — | 125K | 125K |
| Stock Option (Right to Buy) Direct | Common Stock | 2.15 | — | — | 150K | 150K |
| Total | 275K | 275K | ||||